The Animal Model Market size was estimated USD 2.2 billion in 2022 and is expected to reach USD 4.2 billion by 2030 at a CAGR of 8.7% during the forecast period of 2023-2030.

The animal model market is a rapidly growing industry that plays a crucial role in advancing scientific research and development. Animal models, such as mice, rats, rabbits, and primates, are used to study various diseases, test new drugs and therapies, and gain insights into human biology.

One of the key drivers behind the growth of the animal model market is the increasing prevalence of chronic diseases like cancer, cardiovascular disorders, and neurological conditions. Researchers rely on animal models to mimic these diseases in order to understand their underlying mechanisms and develop effective treatments. Additionally, the rising demand for personalized medicine has further fueled the need for animal models that can accurately represent human physiology.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/3789

Moreover, advancements in genetic engineering techniques have revolutionized the animal model market. Scientists can now create genetically modified animals with specific gene mutations or alterations that closely resemble human diseases. These genetically modified animal models provide valuable insights into disease progression and help identify potential therapeutic targets.

Furthermore, pharmaceutical companies heavily rely on animal models during drug discovery and development stages. Animal studies Animal studies play a crucial role in determining the safety and efficacy of potential drug candidates before they can be tested on humans. By using genetically modified animal models, researchers can better understand how a drug interacts with the body and its potential side effects. This knowledge is essential for optimizing drug dosages and minimizing risks during clinical trials. Moreover, these animal models also aid in the development of personalized medicine. By studying how different genetic variations in animals respond to specific treatments, scientists can tailor therapies to individual patients based on their genetic makeup. This approach holds great promise for improving the effectiveness of treatments and reducing adverse reactions. In addition to drug development, genetically modified animal models contribute to advancing our understanding of complex diseases. By introducing specific gene mutations, scientists can mimic the genetic basis of various disorders, such as cancer or neurodegenerative diseases. This allows for detailed investigations into disease mechanisms and the testing of innovative therapeutic strategies. Overall, the use of genetically modified animal models in scientific research and pharmaceutical development has revolutionized our ability to study human diseases and develop effective treatments. These models continue to be invaluable tools in the pursuit of improving human health and well-being.

KEY MARKET SEGMENTS

By Type

·         Mice

·         Rat

·         Guinea Pigs

·         Rabbits

·         Hamsters

·         Others 

By Application

·         Cancer

·         Immunological Disease

·         Infectious Disease

·         Others 

By End User

·         Pharmaceutical & Biotechnology Companies

·         Academic Research Institute

·         Contract Research Organization

Major Players Listed in the Report are as Follows:

Charles River Laboratories, The Jackson Laboratory, genOway, Taconic Biosciences, Inc., Janvier Labs, Harbour BioMed, Crown Bioscience, Inotiv, BIOCYTOGEN, BioSpherix, Ltd., and Others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)